https://dspace.bsmu.edu.ua/handle/123456789/1197 2026-04-14T19:25:41Z 2026-04-14T19:25:41Z Ластівка, І.В. Анцупова, В.В. Заярна, Л.П. https://dspace.bsmu.edu.ua/handle/123456789/20718 2023-03-27T04:02:02Z 2021-01-01T00:00:00Z

Title: Системні скелетні дисплазії: диференційна діагностика Authors: Ластівка, І.В.; Анцупова, В.В.; Заярна, Л.П.

2021-01-01T00:00:00Z Ластівка, І.В. Анцупова, В.В. Заярна, Л.П. https://dspace.bsmu.edu.ua/handle/123456789/20713 2023-03-27T04:05:26Z 2021-01-01T00:00:00Z

Title: Вроджений нефротичний синдром: роль медично-генетичного консультування Authors: Ластівка, І.В.; Анцупова, В.В.; Заярна, Л.П.

2021-01-01T00:00:00Z Sorokman, Tamila V. Moldovan, Pavlo M. Sokolnyk, Iryna S. Koliesnik, Dmytro I. Popelyuk, Natalia O. https://dspace.bsmu.edu.ua/handle/123456789/20701 2023-02-26T18:43:05Z 2022-01-01T00:00:00Z

Title: Concentration of alpha-defensins in the blood plasma of children with Helicobacter pylori – associated peptic ulcer of the duodenum Authors: Sorokman, Tamila V.; Moldovan, Pavlo M.; Sokolnyk, Iryna S.; Koliesnik, Dmytro I.; Popelyuk, Natalia O. Abstract: Various gastrointestinal and extragastric diseases are associated with H. pylori in children and adolescents, but the strongest testing and treatment guidelines are only for children and adolescents with peptic ulcer. The most promising developments now are the study of the antibacterial effect of endogenous antimicrobial peptides (AP), among which the most important are defenses 1-3 (human neutrophil peptides, HNPs 1-3). Objective. To investigate the concentration of HNPs 1-3 in children with H. pylori-associated peptic ulcer of the duodenum (DU).

2022-01-01T00:00:00Z Sorokman, Tamila V. Sokolnyk, Snizhana V. Moldovan, Pavlo M. Chernei, Nadiia Ya. Ostapchuk, Valentuna G. https://dspace.bsmu.edu.ua/handle/123456789/20700 2023-02-26T18:42:51Z 2022-01-01T00:00:00Z

Title: Improvement of eradication therapy in children with duodenal ulcer associated with Helicobacter pylori Authors: Sorokman, Tamila V.; Sokolnyk, Snizhana V.; Moldovan, Pavlo M.; Chernei, Nadiia Ya.; Ostapchuk, Valentuna G. Abstract: The aim: To evaluate the efficacy of the drug VitD children with H.pylori-associated duodenal ulcer. Conclusions: Due to the reduced level of serum VitD in children with H. pylori-associated DU, it is advisable to include in the treatment regimen the adjuvant component of AHBT in the form of VitD. Predictors of effective eradication of H. pylori are CagA (+) strain of H. pylori, duration of infection and VitD level.

2022-01-01T00:00:00Z